Literature DB >> 29979648

First migraine-prevention antibody approved.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29979648     DOI: 10.1038/nbt0718-559b

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  Migraine drug race turns its final corner, FDA decisions in sight.

Authors:  Elie Dolgin
Journal:  Nat Biotechnol       Date:  2018-03-06       Impact factor: 54.908

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.